Brief: Integra LifeSciences Receives FDA 510(k) Clearance for Use of the CUSA Clarity Ultrasonic Surgical Aspirator System for Cardiac Surgeries
11/11/2025 21:16
Nov 12 (Reuters) - Integra Lifesciences Holdings Corp IART.O: INTEGRA LIFESCIENCES RECEIVES FDA 510(K) CLEARANCE FOR USE OF THE CUSA® CLARITY ULTRASONIC SURGICAL ASPIRATOR SYSTEM FOR CARDIAC SURGERIES Source text: ID:nGNX7xxz3N Further company coverage: IART.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Integra LifeSciences Holdings
See all newsIntegra LifeSciences Holdings Corporation reports results for the quarter ended September 30 - Earnings Summary
Integra Lifesciences Q3 revenue slightly misses estimates on flood damage
Brief: Integra Lifesciences - Enters Amended And Restated Credit Agreement On Oct 19, 2026 - SEC Filing
Brief: Integra Announces Completion Of Refinancing Transactions
Brief: Integra Announces Pricing Of Senior Secured Notes